RxDoctor Payments Data

Carol Furnari, PA

Physician Assistant · Gardner, MANPI 1639442825

Payments from drug & device makers

$4,034in general payments, 2019–2025

Across 188 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$516
  • Pfizer$472
  • AstraZeneca$458
  • GSK$328
  • Novo Nordisk$254
  • Lilly USA, LLC$239
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$3,94098%
  • Education$942%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,034 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$37,208
Medicare patients
123
Services billed
619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide45$41,130
MounjaroTirzepatide30$40,048
FarxigaDapagliflozin Propanediol57$36,402
OzempicSemaglutide23$24,690
EliquisApixaban28$22,432
OxycontinOxycodone Hcl25$20,693
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,925
Breo ElliptaFluticasone/Vilanterol35$14,174
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,685
BelsomraSuvorexant19$11,647
Incruse ElliptaUmeclidinium Bromide30$10,497
Bydureon BciseExenatide Microspheres12$9,863
MyrbetriqMirabegron20$9,105
Dexlansoprazole DrDexlansoprazole30$6,757
JardianceEmpagliflozin12$6,532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$239$81,17875 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$458$50,78489 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$328$39,59788 claims
Novo NordiskOzempic$254$24,69023 claims
PfizerEliquis$472$22,43228 claims
MerckBelsomra, Dulera$51$16,06332 claims
Astellas Pharma US IncMyrbetriq$195$9,10520 claims
Boehringer IngelheimJardiance$159$6,53212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Gardner

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →